226 related articles for article (PubMed ID: 27220508)
1. Staging PET-CT Scanning Provides Superior Detection of Lymph Nodes and Distant Metastases than Traditional Imaging in Locally Advanced Breast Cancer.
Garg PK; Deo SV; Kumar R; Shukla NK; Thulkar S; Gogia A; Sharma DN; Mathur SR
World J Surg; 2016 Aug; 40(8):2036-42. PubMed ID: 27220508
[TBL] [Abstract][Full Text] [Related]
2. Whole-body
Gajjala SR; Hulikal N; Kadiyala S; Kottu R; Kalawat T
Indian J Med Res; 2018 Mar; 147(3):256-262. PubMed ID: 29923514
[TBL] [Abstract][Full Text] [Related]
3. The role of (18)F-FDG PET/CT in initial staging of patients with locally advanced breast carcinoma with an emphasis on M staging.
Mittal BR; Manohar K; Kashyap R; Bhattacharya A; Singh B; Singh G
Hell J Nucl Med; 2011; 14(2):135-9. PubMed ID: 21761015
[TBL] [Abstract][Full Text] [Related]
4. Impact of Pretreatment Combined (18)F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Staging on Radiation Therapy Treatment Decisions in Locally Advanced Breast Cancer.
Ng SP; David S; Alamgeer M; Ganju V
Int J Radiat Oncol Biol Phys; 2015 Sep; 93(1):111-7. PubMed ID: 26279029
[TBL] [Abstract][Full Text] [Related]
5. Preoperative staging of large primary breast cancer with [18F]fluorodeoxyglucose positron emission tomography/computed tomography compared with conventional imaging procedures.
Fuster D; Duch J; Paredes P; Velasco M; Muñoz M; Santamaría G; Fontanillas M; Pons F
J Clin Oncol; 2008 Oct; 26(29):4746-51. PubMed ID: 18695254
[TBL] [Abstract][Full Text] [Related]
6. Fluorine-18 2-deoxy-2-fluoro-D-glucose PET in the preoperative staging of breast cancer: comparison with the standard staging procedures.
Schirrmeister H; Kühn T; Guhlmann A; Santjohanser C; Hörster T; Nüssle K; Koretz K; Glatting G; Rieber A; Kreienberg R; Buck AC; Reske SN
Eur J Nucl Med; 2001 Mar; 28(3):351-8. PubMed ID: 11315604
[TBL] [Abstract][Full Text] [Related]
7. 18F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) imaging in the staging and prognosis of inflammatory breast cancer.
Alberini JL; Lerebours F; Wartski M; Fourme E; Le Stanc E; Gontier E; Madar O; Cherel P; Pecking AP
Cancer; 2009 Nov; 115(21):5038-47. PubMed ID: 19645022
[TBL] [Abstract][Full Text] [Related]
8. 18F-2-fluoro-2-deoxy-d-glucose positron emission tomography in staging of locally advanced breast cancer.
van der Hoeven JJ; Krak NC; Hoekstra OS; Comans EF; Boom RP; van Geldere D; Meijer S; van der Wall E; Buter J; Pinedo HM; Teule GJ; Lammertsma AA
J Clin Oncol; 2004 Apr; 22(7):1253-9. PubMed ID: 15051773
[TBL] [Abstract][Full Text] [Related]
9. Histopathologic validation of lymph node staging with FDG-PET scan in cancer of the esophagus and gastroesophageal junction: A prospective study based on primary surgery with extensive lymphadenectomy.
Lerut T; Flamen P; Ectors N; Van Cutsem E; Peeters M; Hiele M; De Wever W; Coosemans W; Decker G; De Leyn P; Deneffe G; Van Raemdonck D; Mortelmans L
Ann Surg; 2000 Dec; 232(6):743-52. PubMed ID: 11088069
[TBL] [Abstract][Full Text] [Related]
10. Role of 18F-FDG PET/CT in identifying distant metastatic disease missed by conventional imaging in patients with locally advanced breast cancer.
Manohar K; Mittal BR; Bhoil A; Bhattacharya A; Singh G
Nucl Med Commun; 2013 Jun; 34(6):557-61. PubMed ID: 23549551
[TBL] [Abstract][Full Text] [Related]
11. 18F-FDG PET/CT as a staging procedure in primary stage II and III breast cancer: comparison with conventional imaging techniques.
Koolen BB; Vrancken Peeters MJ; Aukema TS; Vogel WV; Oldenburg HS; van der Hage JA; Hoefnagel CA; Stokkel MP; Loo CE; Rodenhuis S; Rutgers EJ; Valdés Olmos RA
Breast Cancer Res Treat; 2012 Jan; 131(1):117-26. PubMed ID: 21935602
[TBL] [Abstract][Full Text] [Related]
12. Impact of
Dayes IS; Metser U; Hodgson N; Parpia S; Eisen AF; George R; Blanchette P; Cil TD; Arnaout A; Chan A; Levine MN
J Clin Oncol; 2023 Aug; 41(23):3909-3916. PubMed ID: 37235845
[TBL] [Abstract][Full Text] [Related]
13. Lack of clinical impact of
Liu J; Larcos G; Howle J; Veness M
Australas J Dermatol; 2017 May; 58(2):99-105. PubMed ID: 26459330
[TBL] [Abstract][Full Text] [Related]
14. 18F-FDG PET/CT in staging patients with locally advanced or inflammatory breast cancer: comparison to conventional staging.
Groheux D; Giacchetti S; Delord M; Hindié E; Vercellino L; Cuvier C; Toubert ME; Merlet P; Hennequin C; Espié M
J Nucl Med; 2013 Jan; 54(1):5-11. PubMed ID: 23213197
[TBL] [Abstract][Full Text] [Related]
15. The role of FDG PET/CT in detection of distant metastasis in theinitial staging of breast cancer.
Aliyev A; Yilmaz Aksoy S; Özhan M; Ekmekçioğlu Ö; Vatankulu B; Kocael PÇ; Sağer MS; Erkan ME; Sönmezoğlu K; Halaç M
Turk J Med Sci; 2016 Feb; 46(2):349-60. PubMed ID: 27511496
[TBL] [Abstract][Full Text] [Related]
16. Comparison of 18F-FDG PET/CT for Systemic Staging of Newly Diagnosed Invasive Lobular Carcinoma Versus Invasive Ductal Carcinoma.
Hogan MP; Goldman DA; Dashevsky B; Riedl CC; Gönen M; Osborne JR; Jochelson M; Hudis C; Morrow M; Ulaner GA
J Nucl Med; 2015 Nov; 56(11):1674-80. PubMed ID: 26294295
[TBL] [Abstract][Full Text] [Related]
17. Inefficacy of F-18 fluorodeoxy-D-glucose-positron emission tomography scans for initial evaluation in early-stage cutaneous melanoma.
Wagner JD; Schauwecker D; Davidson D; Logan T; Coleman JJ; Hutchins G; Love C; Wenck S; Daggy J
Cancer; 2005 Aug; 104(3):570-9. PubMed ID: 15977211
[TBL] [Abstract][Full Text] [Related]
18. [18F]FDG PET/CT in the staging of inflammatory breast cancer: A systematic review.
van Uden DJP; Prins MW; Siesling S; de Wilt JHW; Blanken-Peeters CFJM; Aarntzen EHJG
Crit Rev Oncol Hematol; 2020 Jul; 151():102943. PubMed ID: 32416347
[TBL] [Abstract][Full Text] [Related]
19. A comparative study of 18F-FDG PET/CT and ultrasonography in the diagnosis of breast cancer and axillary lymph node metastasis.
He X; Sun L; Huo Y; Shao M; Ma C
Q J Nucl Med Mol Imaging; 2017 Dec; 61(4):429-437. PubMed ID: 25823388
[TBL] [Abstract][Full Text] [Related]
20. (18) F-FDG PET/CT for initial staging in breast cancer patients - Is there a relevant impact on treatment planning compared to conventional staging modalities?
Krammer J; Schnitzer A; Kaiser CG; Buesing KA; Sperk E; Brade J; Wasgindt S; Suetterlin M; Schoenberg SO; Sutton EJ; Wasser K
Eur Radiol; 2015 Aug; 25(8):2460-9. PubMed ID: 25680729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]